- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/14 - Decongestants or antiallergics
Patent holdings for IPC class A61P 27/14
Total number of patents in this class: 323
10-year publication summary
8
|
11
|
18
|
12
|
12
|
20
|
16
|
8
|
10
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Santen Pharmaceutical Co., Ltd. | 601 |
15 |
Daiichi Sankyo Company, Limited | 1886 |
10 |
Dainippon Sumitomo Pharma Co., Ltd. | 193 |
8 |
Senju Pharmaceutical Co., Ltd. | 226 |
7 |
Glenmark Specialty S.A. | 77 |
6 |
Taisho Pharmaceutical Co., Ltd. | 866 |
6 |
AstraZeneca AB | 2899 |
5 |
Alcon Research, Ltd. | 350 |
4 |
Aldeyra Therapeutics, Inc. | 109 |
4 |
Allakos Inc. | 60 |
4 |
Bausch & Lomb Incorporated | 1106 |
4 |
Industry-Academic Cooperation Foundation, Yonsei University | 2414 |
4 |
Novartis AG | 10726 |
3 |
Takeda Pharmaceutical Company Limited | 2707 |
3 |
Ewha University-industry Collaboration Foundation | 732 |
3 |
KYORIN Pharmaceutical Co., Ltd. | 167 |
3 |
NTC S.r.l. | 78 |
3 |
Ora, Inc. | 21 |
3 |
Otsuka Pharmaceutical Co., Ltd. | 1491 |
3 |
Shionogi & Co., Ltd. | 849 |
3 |
Other owners | 222 |